[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:melasma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":36,"states":37},"Melasma",4,2,[8,15,21,29],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06868615","AVAVA MIRIA General Use",[],"RECRUITING","2026-08-26T02:16:22.235886Z","2026-05-05T02:43:28.851102Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05942248","The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis",[],"2026-08-26T02:16:04.914942Z","2026-05-05T02:43:27.174758Z",{"nct_id":22,"title":23,"phases":24,"status":26,"updated_at":27,"content_modified":28},"NCT07136766","An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product",[25],"Phase 3","ENROLLING_BY_INVITATION","2026-08-26T02:19:10.436356Z","2026-06-16T05:54:07.857237Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT06415435","Sylfirm X Radiofrequency Microneedling for the Treatment of Melasma",[],"UNKNOWN","2026-08-03T01:55:52.940420Z","2026-05-05T02:43:26.851404Z",[],[]]